Follow
Margarita Sanchez-Beato
Margarita Sanchez-Beato
Instituto Investigación Sanitaria Puerta de Hierro-Segovia de Arana (IDIPHISA)
Verified email at idiphim.org - Homepage
Title
Cited by
Cited by
Year
Cell cycle deregulation in B-cell lymphomas
M Sánchez-Beato, A Sánchez-Aguilera, MA Piris
Blood, The Journal of the American Society of Hematology 101 (4), 1220-1235, 2003
5092003
Structural profiles of TP53 gene mutations predict clinical outcome in diffuse large B-cell lymphoma: an international collaborative study
KH Young, K Leroy, MB Møller, GWB Colleoni, M Sánchez-Beato, ...
Blood, The Journal of the American Society of Hematology 112 (8), 3088-3098, 2008
2592008
p53 and bcl-2 expression in high-grade B-cell lymphomas: correlation with survival time
MA Piris, F Pezzella, JC Martinez-Montero, JL Orradre, R Villuendas, ...
British Journal of Cancer 69 (2), 337-341, 1994
2421994
PLCG1 mutations in cutaneous T-cell lymphomas
JP Vaqué, G Gómez-López, V Monsálvez, I Varela, N Martínez, C Pérez, ...
Blood, The Journal of the American Society of Hematology 123 (13), 2034-2043, 2014
2322014
Analysis of the IgVH somatic mutations in splenic marginal zone lymphoma defines a group of unmutated cases with frequent 7q deletion and adverse clinical …
P Algara, MS Mateo, M Sanchez-Beato, M Mollejo, IC Navas, L Romero, ...
Blood, The Journal of the American Society of Hematology 99 (4), 1299-1304, 2002
2082002
Adverse clinical outcome in Hodgkin's disease is associated with loss of retinoblastoma protein expression, high Ki67 proliferation index, and absence of Epstein-Barr virus …
MM Morente, MA Piris, V Abraira, A Acevedo, B Aguilera, C Bellas, ...
Blood, The Journal of the American Society of Hematology 90 (6), 2429-2436, 1997
1721997
Molecular heterogeneity in MCL defined by the use of specificVH genes and the frequency of somatic mutations
FI Camacho, P Algara, A Rodrıguez, E Ruız-Ballesteros, M Mollejo, ...
Blood, The Journal of the American Society of Hematology 101 (10), 4042-4046, 2003
1712003
7q31-32 allelic loss is a frequent finding in splenic marginal zone lymphoma
M Mateo, M Mollejo, R Villuendas, P Algara, M Sanchez-Beato, ...
The American journal of pathology 154 (5), 1583-1589, 1999
1711999
Progression to large B-cell lymphoma in splenic marginal zone lymphoma: a description of a series of 12 cases
FI Camacho, M Mollejo, MS Mateo, P Algara, C Navas, JM Hernández, ...
The American journal of surgical pathology 25 (10), 1268-1276, 2001
1692001
Anomalous high p27/KIP1 expression in a subset of aggressive B-cell lymphomas is associated with cyclin D3 overexpression. p27/KIP1—cyclin D3 colocalization in tumor cells
M Sánchez-Beato, FI Camacho, JC Martı́nez-Montero, AI Sáez, ...
Blood, The Journal of the American Society of Hematology 94 (2), 765-772, 1999
1551999
Loss of p16/INK4A protein expression in non-Hodgkin's lymphomas is a frequent finding associated with tumor progression
R Villuendas, M Sánchez-Beato, JC Martínez, AI Saez, ...
The American journal of pathology 153 (3), 887-897, 1998
1551998
Cancer induction by restriction of oncogene expression to the stem cell compartment
M Pérez‐Caro, C Cobaleda, I González‐Herrero, C Vicente‐Dueñas, ...
The EMBO journal 28 (1), 8-20, 2009
1492009
Cyclin-dependent kinase inhibitor p27KIP1 in lymphoid tissue: p27KIP1 expression is inversely proportional to the proliferative index.
M Sanchez-Beato, AI Saez, JC Martinez-Montero, MS Mateo, ...
The American journal of pathology 151 (1), 151, 1997
1341997
The expression of p53 protein in non-Hodgkin's lymphomas is not always dependent on p53 gene mutations
R Villuendas, MA Piris, P Algara, M Sanchez-Beato, L Sánchez-Verde, ...
1301993
Nodal marginal zone lymphoma: a heterogeneous tumor: a comprehensive analysis of a series of 27 cases
FI Camacho, P Algara, M Mollejo, JF García, C Montalbán, N Martínez, ...
The American journal of surgical pathology 27 (6), 762-771, 2003
1262003
MicroRNA signatures in B-cell lymphomas
L Di Lisio, M Sánchez-Beato, G Gómez-López, ME Rodríguez, ...
Blood cancer journal 2 (2), e57-e57, 2012
1132012
Variability in the expression of polycomb proteins in different normal and tumoral tissues. A pilot study using tissue microarrays
M Sánchez-Beato, E Sánchez, J González-Carreró, M Morente, A Díez, ...
Modern pathology 19 (5), 684-694, 2006
1122006
Nodal marginal zone lymphoma: gene expression and miRNA profiling identify diagnostic markers and potential therapeutic targets
AJ Arribas, Y Campos-Martín, C Gómez-Abad, P Algara, ...
Blood, The Journal of the American Society of Hematology 119 (3), e9-e21, 2012
1062012
Overall survival in aggressive B-cell lymphomas is dependent on the accumulation of alterations in p53, p16, and p27
M Sánchez-Beato, AI Sáez, IC Navas, P Algara, MS Mateo, R Villuendas, ...
The American journal of pathology 159 (1), 205-213, 2001
1062001
PIM2 inhibition as a rational therapeutic approach in B-cell lymphoma
C Gomez-Abad, H Pisonero, C Blanco-Aparicio, G Roncador, ...
Blood, The Journal of the American Society of Hematology 118 (20), 5517-5527, 2011
1052011
The system can't perform the operation now. Try again later.
Articles 1–20